Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Viewpoints: Looking for the budget's true bottom line; The debate on Plan B reignited; Medicare cuts have impact

President Obama will release his overdue budget on Wednesday. It will doubtless project a reduction in the federal budget deficit - a projection that journalists, commentators and policy makers should ignore.

10 Apr 2013

Animal robots for dementia treatment: an interview with Professor Wendy Moyle, Griffith University

A robotic cat was first trialled in the US in early 2004 as a companion pet for people with dementia. A number of nursing homes have either ‘toy’ or robotic animals that they use as entertainment for older residents as well as people with dementia.

5 Apr 2013

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Schizophrenia patients experiencing relapse are 29 times more likely than healthy individuals to have a urinary tract infection, researchers report.

4 Apr 2013

New evidence shows older adults with dementia can be taken off antipsychotic medications

Most older adults with dementia can successfully be taken off antipsychotic medications, which have negative side effects and increase the risk of death, finds a new evidence review from The Cochrane Library.

29 Mar 2013

Academic medical centers launch ASD sub-registry within ResearchMatch

Each year, only five percent of the estimated 1.5 million children with an autism spectrum disorder in the US participate in clinical research studies. This is in stark contrast to pediatric cancer studies, which have a nearly 90 percent enrollment rate - a rate that has helped advance treatment and outcomes for childhood cancers substantially in the last decade.

27 Mar 2013

Alarming report on persistent side effects of antidepressant drugs published online

An alarming report from patient online websites on persistent side effects of antidepressant drugs has been published in one of the last issue of Psychotherapy and Psychosomatics by investigators from the University of Bologna and North America.

21 Mar 2013

Study finds increased use of antipsychotic medication among Medicaid-insured children

A new study from the University of Maryland found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages two to 17.

16 Mar 2013

Antipsychotic drugs associated with increased risk of stroke in the elderly

Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into this important relationship.

12 Mar 2013

Researchers develop new approach to screening potential treatments for Alzheimer's disease

According to a 2012 World Health Organization report, over 35 million people worldwide currently have dementia, a number that is expected to double by 2030 (66 million) and triple by 2050 (115 million).

11 Mar 2013

Inflammatory marker for schizophrenia treatment resistance, severity

Levels of the inflammatory marker soluble tumor necrosis factor receptor 1 may be associated with severity of symptoms and treatment resistance in schizophrenia, say Brazilian scientists.

8 Mar 2013

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients.

7 Mar 2013

Quitting cannabis may not alleviate psychosis

The amount of cannabis used does not appear to be associated with the severity of symptoms in patients with established psychosis, although the drug is linked to a small effect on psychosocial functioning, say UK scientists.

5 Mar 2013

Report: Drug companies spent $84M marketing pharmaceuticals in the District of Columbia in 2011

Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according to a report by researchers at the George Washington University School of Public Health and Health Services.

2 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Antipsychotic News and Research

Viewpoints: Looking for the budget's true bottom line; The debate on Plan B reignited; Medicare cuts have impact

Animal robots for dementia treatment: an interview with Professor Wendy Moyle, Griffith University

Schizophrenia patients experiencing relapse are more likely to develop UTIs

New evidence shows older adults with dementia can be taken off antipsychotic medications

Academic medical centers launch ASD sub-registry within ResearchMatch

Alarming report on persistent side effects of antidepressant drugs published online

Study finds increased use of antipsychotic medication among Medicaid-insured children

Antipsychotic drugs associated with increased risk of stroke in the elderly

Researchers develop new approach to screening potential treatments for Alzheimer's disease

Inflammatory marker for schizophrenia treatment resistance, severity

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Quitting cannabis may not alleviate psychosis

Report: Drug companies spent $84M marketing pharmaceuticals in the District of Columbia in 2011

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Bipolar disorder associated with increased hypertension risk

Cardiometabolic risk prevention opportunity in early schizophrenia

Antipsychotic drug dispensing on the rise among older people

First-episode psychosis hits men hard

Schizophrenia dampens volition

Metabolic syndrome risk factors prevalent in bipolar disorder

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News